Preview, a Full View of Genetic Risk Building on Nucleus Family, introduced last year, Preview is a more advanced preconception experience and a redefinition of what carrier screening is. What began ...

Following Nucleus RadioPharma’s 2022 debut, the GE HealthCare- and Mayo Clinic-backed radiopharmaceuticals CDMO is ready to put its production thesis to the test. Nucleus on Tuesday revealed that it ...

Nucleus Genomics, a genetic testing company focused on calculating a patient’s risk of certain diseases, is adding $14 million to their initial seed funding round. With this round the company has ...

When COVID-19 closed down most of society in 2020, Kian Sadeghi, like many of his then-classmates at the University of Pennsylvania, found himself holed up in his bedroom. He prefers it that way.

The cell nucleus is considered to be the control center of vital cellular processes, but its material properties continue to puzzle scientists. An international research team led by MedUni Vienna has ...